• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质瘤治疗的未来:干细胞、纳米技术和个性化医疗。

The future of glioma treatment: stem cells, nanotechnology and personalized medicine.

机构信息

Department of Neurosurgery, University of Florida, Box 100265, Gainesville, FL 32610, USA.

出版信息

Future Oncol. 2012 Sep;8(9):1149-56. doi: 10.2217/fon.12.111.

DOI:10.2217/fon.12.111
PMID:23030489
Abstract

The development of novel therapies, imaging techniques and insights into the processes that drive growth of CNS tumors have allowed growing enthusiasm for the treatment of CNS malignancies. Despite this energized effort to investigate and treat brain cancer, clinical outcomes for most patients continue to be dismal. Recognition of diverse tumor subtypes, behaviors and outcomes has led to an interest in personalized medicine for the treatment of brain tumors. This new paradigm requires evaluation of the tumor phenotype at the time of diagnosis so that therapy can be specifically tailored to each individual patient. Investigating novel therapies involving stem cells, nanotechnology and molecular medicine will allow diversity of therapeutic options for patients with brain cancer. These exciting new therapeutic strategies for brain tumors are reviewed in this article.

摘要

新型治疗方法、成像技术以及对中枢神经系统肿瘤生长过程的深入了解,使得人们对中枢神经系统恶性肿瘤的治疗产生了越来越大的热情。尽管人们在努力研究和治疗脑癌方面做出了不懈的努力,但大多数患者的临床预后仍然不容乐观。不同肿瘤亚型、行为和结果的认识促使人们对脑肿瘤的个性化治疗产生了兴趣。这种新模式需要在诊断时评估肿瘤表型,以便能够根据每个患者的具体情况定制治疗方案。研究涉及干细胞、纳米技术和分子医学的新型治疗方法将为脑癌患者提供多样化的治疗选择。本文综述了脑肿瘤的这些令人兴奋的新治疗策略。

相似文献

1
The future of glioma treatment: stem cells, nanotechnology and personalized medicine.胶质瘤治疗的未来:干细胞、纳米技术和个性化医疗。
Future Oncol. 2012 Sep;8(9):1149-56. doi: 10.2217/fon.12.111.
2
Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.恶性脑胶质瘤的局部治疗现状——三种选定方法的临床评价。
Pharmacol Ther. 2013 Sep;139(3):341-58. doi: 10.1016/j.pharmthera.2013.05.003. Epub 2013 May 18.
3
Diagnostic and prognostic molecular markers in common adult gliomas.常见成人脑胶质瘤的诊断和预后分子标志物。
Expert Rev Mol Diagn. 2010 Jul;10(5):637-49. doi: 10.1586/erm.10.44.
4
The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy.载药纳米颗粒系统与成体干细胞联合用于神经胶质瘤治疗的潜力。
Biomaterials. 2011 Mar;32(8):2106-16. doi: 10.1016/j.biomaterials.2010.11.056. Epub 2010 Dec 22.
5
Novel therapies for malignant gliomas.恶性胶质瘤的新型治疗方法。
Neurol Clin. 2007 Nov;25(4):1141-71, x. doi: 10.1016/j.ncl.2007.07.012.
6
[A practical guide for the management of gliomas].[胶质瘤管理实用指南]
Bull Cancer. 2007 Sep;94(9):817-22.
7
Diagnosis and treatment of recurrent high-grade astrocytoma.复发性高级别星形细胞瘤的诊断与治疗
J Clin Oncol. 2006 Mar 10;24(8):1273-80. doi: 10.1200/JCO.2005.04.7522.
8
[Glioma treatment strategies using mesenchymal stem cells].[使用间充质干细胞的胶质瘤治疗策略]
Brain Nerve. 2010 Oct;62(10):1075-82.
9
Clinical trials in cellular immunotherapy for brain/CNS tumors.脑/CNS 肿瘤细胞免疫治疗的临床试验。
Expert Rev Neurother. 2013 Apr;13(4):405-24. doi: 10.1586/ern.13.23.
10
Immunotherapy targeting glioma stem cells--insights and perspectives.针对神经胶质瘤干细胞的免疫疗法——见解与展望。
Expert Opin Biol Ther. 2012 Feb;12(2):165-78. doi: 10.1517/14712598.2012.648180. Epub 2011 Dec 26.

引用本文的文献

1
Diffuse intrinsic pontine glioma (DIPG): A review of current and emerging treatment strategies.弥漫性脑桥内生型胶质瘤(DIPG):当前及新兴治疗策略综述
Cancer Lett. 2024 May 28;590:216876. doi: 10.1016/j.canlet.2024.216876. Epub 2024 Apr 10.
2
Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy.突破血脑屏障治疗脑癌的挑战与机遇。
Theranostics. 2022 Jun 6;12(10):4734-4752. doi: 10.7150/thno.69682. eCollection 2022.
3
Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review.
用于神经胶质瘤的纳米颗粒药物传递系统及其疗效改善策略:全面综述。
Int J Nanomedicine. 2020 Apr 17;15:2563-2582. doi: 10.2147/IJN.S243223. eCollection 2020.
4
Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma.纳米技术在弥漫性脑桥内在型胶质瘤中的应用
Curr Neuropharmacol. 2017;15(1):104-115. doi: 10.2174/1570159x14666160223121002.
5
Penetrating the Blood-Brain Barrier: Promise of Novel Nanoplatforms and Delivery Vehicles.穿透血脑屏障:新型纳米平台与递送载体的前景
ACS Nano. 2015 Oct 27;9(10):9470-4. doi: 10.1021/acsnano.5b05341. Epub 2015 Sep 25.
6
Klotho, stem cells, and aging.klotho、干细胞与衰老
Clin Interv Aging. 2015 Aug 4;10:1233-43. doi: 10.2147/CIA.S84978. eCollection 2015.
7
Bionanotechnology and the future of glioma.生物纳米技术与神经胶质瘤的未来
Surg Neurol Int. 2015 Feb 13;6(Suppl 1):S45-58. doi: 10.4103/2152-7806.151334. eCollection 2015.
8
Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-κB signaling.升高的TAK1通过激活NF-κB信号通路增强卵巢癌细胞的肿瘤生长和转移能力。
Oncotarget. 2014 Sep 15;5(17):7549-62. doi: 10.18632/oncotarget.2273.
9
Conditioned media from human adipose tissue-derived mesenchymal stem cells and umbilical cord-derived mesenchymal stem cells efficiently induced the apoptosis and differentiation in human glioma cell lines in vitro.来自人脂肪组织间充质干细胞和脐带间充质干细胞的条件培养基在体外能有效诱导人胶质瘤细胞系的凋亡和分化。
Biomed Res Int. 2014;2014:109389. doi: 10.1155/2014/109389. Epub 2014 May 27.
10
Molecular culprits generating brain tumor stem cells.产生脑肿瘤干细胞的分子元凶。
Brain Tumor Res Treat. 2013 Apr;1(1):9-15. doi: 10.14791/btrt.2013.1.1.9. Epub 2013 Apr 30.